by hleonhardt | Jul 23, 2020 | News, Uncategorized
First Long-Duration Clinical Studies in Cardio-Renal Syndrome Patients Now Scheduled to Take Place July 2020 in Tbilisi, Georgia NEWS PROVIDED BY Second Heart Assist, Inc. June 22nd, 2020 7:00am ET Salt Lake City, Utah, June 22nd, 2020 /PRDistribution/ — Second...
by hleonhardt | Jul 23, 2020 | News, Uncategorized
May Also by Useful in Treating Osteoporosis by startup OrthoStim July 2nd, 2020 IRVINE, CALIFORNIA –(PR Distribution)- CancerCell www.cancercellinc.com, a biotechnology LTP stage startup within the Leonhardt’s Launchpads innovation and startup launch...
by hleonhardt | Jul 23, 2020 | News, Uncategorized
Data show patients treated with BladderCell non-invasive bioelectric stimulation system improved urinary incontinence symptoms and quality of life. BladderCell is a medical technology platform within the Leonhardt’s Launchpads innovation and startup launch...
by hleonhardt | Jun 5, 2020 | News, Uncategorized
Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Regenerative Protein Expressions Including Stem Cell Homing and Differentiation Control Technology Has Key Potential Applications in Regeneration of...
by hleonhardt | May 28, 2020 | News, Uncategorized
Salt Lake City, UT (April 30th, 2020) – Following blind peer review, Second Heart Assist’s clinical data presentation has been selected for oral presentation at the American Society of Artificial Organs (ASAIO) 66th annual conference, scheduled to be held...
by hleonhardt | May 28, 2020 | News, Uncategorized
Salt Lake City, Utah, May 7th, 2020 – Second Heart Assist, the innovative developers of the world’s first percutaneous placed true aortic stent based circulatory assist pumps, are delighted to announce that they will provide a brief update on their...
